Heparinase I from Flavobacterium heparinum: The Role of the Cysteine Residue in Catalysis as Probed by Chemical Modification and Site-Directed Mutagenesis

Ram Sasisekharan, Deborah Leckband, Ranga Godavarti, Ganesh Venkataraman, Charles L. Cooney, Robert Langer

Research output: Contribution to journalArticle

Abstract

Heparinase I (heparin lyase I, EC 4.2.2.7), a heparin-degrading enzyme produced by Flavobacterium heparinum, is used to deheparinize blood following extracorporeal procedures in surgery and in other applications. The present study of mapping and characterization of the cysteines of heparinase I represents the first structural characterization of a heparinase. [3H]Iodoacetic acid labeling demonstrated that heparinase I has two free cysteines. One of the two cysteines is surface accessible and lies in a hydrophilic environment while the other is in a hydrophobic environment. Chemical modification of the cysteines, both in the presence and in the absence of heparin, suggests that the surface-accessible cysteine lies in or near the active site of heparinase I. Preferential reactivity of this cysteine with negatively charged sulfhydryl-modifying reagents and the cysteines' high reactivity to iodoacetic acid at pH 6.5 indicate that the surface-accessible cysteine is in a positively charged region. The surface- accessible cysteine (cysteine-135) was mapped as the active-site cysteine by radiolabeling with [3H]iodoacetic acid and by tryptic digestion and peptide sequencing. Site-directed mutagenesis of cysteine-135 to a serine or an alanine in r-heparinase I demonstrates that this cysteine is essential for enzymatic activity. However, replacement of the surface-inaccessible cysteine by a serine or alanine has no effect.

Original languageEnglish (US)
Pages (from-to)14441-14448
Number of pages8
JournalBiochemistry
Volume34
Issue number44
DOIs
StatePublished - Nov 1995
Externally publishedYes

Fingerprint

Heparin Lyase
Flavobacterium
Mutagenesis
Chemical modification
Site-Directed Mutagenesis
Catalysis
Cysteine
Iodoacetic Acid
Alanine
Serine
Heparin
Catalytic Domain
Sulfhydryl Reagents

ASJC Scopus subject areas

  • Biochemistry

Cite this

Heparinase I from Flavobacterium heparinum : The Role of the Cysteine Residue in Catalysis as Probed by Chemical Modification and Site-Directed Mutagenesis. / Sasisekharan, Ram; Leckband, Deborah; Godavarti, Ranga; Venkataraman, Ganesh; Cooney, Charles L.; Langer, Robert.

In: Biochemistry, Vol. 34, No. 44, 11.1995, p. 14441-14448.

Research output: Contribution to journalArticle

Sasisekharan, Ram ; Leckband, Deborah ; Godavarti, Ranga ; Venkataraman, Ganesh ; Cooney, Charles L. ; Langer, Robert. / Heparinase I from Flavobacterium heparinum : The Role of the Cysteine Residue in Catalysis as Probed by Chemical Modification and Site-Directed Mutagenesis. In: Biochemistry. 1995 ; Vol. 34, No. 44. pp. 14441-14448.
@article{27efc5d95b654450a1f3d22ad67faf17,
title = "Heparinase I from Flavobacterium heparinum: The Role of the Cysteine Residue in Catalysis as Probed by Chemical Modification and Site-Directed Mutagenesis",
abstract = "Heparinase I (heparin lyase I, EC 4.2.2.7), a heparin-degrading enzyme produced by Flavobacterium heparinum, is used to deheparinize blood following extracorporeal procedures in surgery and in other applications. The present study of mapping and characterization of the cysteines of heparinase I represents the first structural characterization of a heparinase. [3H]Iodoacetic acid labeling demonstrated that heparinase I has two free cysteines. One of the two cysteines is surface accessible and lies in a hydrophilic environment while the other is in a hydrophobic environment. Chemical modification of the cysteines, both in the presence and in the absence of heparin, suggests that the surface-accessible cysteine lies in or near the active site of heparinase I. Preferential reactivity of this cysteine with negatively charged sulfhydryl-modifying reagents and the cysteines' high reactivity to iodoacetic acid at pH 6.5 indicate that the surface-accessible cysteine is in a positively charged region. The surface- accessible cysteine (cysteine-135) was mapped as the active-site cysteine by radiolabeling with [3H]iodoacetic acid and by tryptic digestion and peptide sequencing. Site-directed mutagenesis of cysteine-135 to a serine or an alanine in r-heparinase I demonstrates that this cysteine is essential for enzymatic activity. However, replacement of the surface-inaccessible cysteine by a serine or alanine has no effect.",
author = "Ram Sasisekharan and Deborah Leckband and Ranga Godavarti and Ganesh Venkataraman and Cooney, {Charles L.} and Robert Langer",
year = "1995",
month = "11",
doi = "10.1021/bi00044a022",
language = "English (US)",
volume = "34",
pages = "14441--14448",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "44",

}

TY - JOUR

T1 - Heparinase I from Flavobacterium heparinum

T2 - The Role of the Cysteine Residue in Catalysis as Probed by Chemical Modification and Site-Directed Mutagenesis

AU - Sasisekharan, Ram

AU - Leckband, Deborah

AU - Godavarti, Ranga

AU - Venkataraman, Ganesh

AU - Cooney, Charles L.

AU - Langer, Robert

PY - 1995/11

Y1 - 1995/11

N2 - Heparinase I (heparin lyase I, EC 4.2.2.7), a heparin-degrading enzyme produced by Flavobacterium heparinum, is used to deheparinize blood following extracorporeal procedures in surgery and in other applications. The present study of mapping and characterization of the cysteines of heparinase I represents the first structural characterization of a heparinase. [3H]Iodoacetic acid labeling demonstrated that heparinase I has two free cysteines. One of the two cysteines is surface accessible and lies in a hydrophilic environment while the other is in a hydrophobic environment. Chemical modification of the cysteines, both in the presence and in the absence of heparin, suggests that the surface-accessible cysteine lies in or near the active site of heparinase I. Preferential reactivity of this cysteine with negatively charged sulfhydryl-modifying reagents and the cysteines' high reactivity to iodoacetic acid at pH 6.5 indicate that the surface-accessible cysteine is in a positively charged region. The surface- accessible cysteine (cysteine-135) was mapped as the active-site cysteine by radiolabeling with [3H]iodoacetic acid and by tryptic digestion and peptide sequencing. Site-directed mutagenesis of cysteine-135 to a serine or an alanine in r-heparinase I demonstrates that this cysteine is essential for enzymatic activity. However, replacement of the surface-inaccessible cysteine by a serine or alanine has no effect.

AB - Heparinase I (heparin lyase I, EC 4.2.2.7), a heparin-degrading enzyme produced by Flavobacterium heparinum, is used to deheparinize blood following extracorporeal procedures in surgery and in other applications. The present study of mapping and characterization of the cysteines of heparinase I represents the first structural characterization of a heparinase. [3H]Iodoacetic acid labeling demonstrated that heparinase I has two free cysteines. One of the two cysteines is surface accessible and lies in a hydrophilic environment while the other is in a hydrophobic environment. Chemical modification of the cysteines, both in the presence and in the absence of heparin, suggests that the surface-accessible cysteine lies in or near the active site of heparinase I. Preferential reactivity of this cysteine with negatively charged sulfhydryl-modifying reagents and the cysteines' high reactivity to iodoacetic acid at pH 6.5 indicate that the surface-accessible cysteine is in a positively charged region. The surface- accessible cysteine (cysteine-135) was mapped as the active-site cysteine by radiolabeling with [3H]iodoacetic acid and by tryptic digestion and peptide sequencing. Site-directed mutagenesis of cysteine-135 to a serine or an alanine in r-heparinase I demonstrates that this cysteine is essential for enzymatic activity. However, replacement of the surface-inaccessible cysteine by a serine or alanine has no effect.

UR - http://www.scopus.com/inward/record.url?scp=0028829797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028829797&partnerID=8YFLogxK

U2 - 10.1021/bi00044a022

DO - 10.1021/bi00044a022

M3 - Article

C2 - 7578049

AN - SCOPUS:0028829797

VL - 34

SP - 14441

EP - 14448

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 44

ER -